Use access key #2 to skip to page content.
$49.45 -0.44 (-0.88%)
10/10/2008 4:01 PM

Abbott Laboratories (ABT)

CAPS Rating:
****

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

View All Commentary (ABT)

Recs

2

Avatar ibarz (91.98) Submitted: 10/05/06 2:52 PM : Outperform Start Price: $44.76 ABT Score: 44.95

This is a must have for healthcare/pharma. A long term hold for its product pipeline, especially in the stent/drug coated stent business it got from Boston Scientific/Guidant deal.
Practically all analyst reports indicate the ABT is the only winner in that BSX/GDT merger. I bought this at $39, but I'm adding even here at $46.

Report this Post Replies: 0 | Reply

Featured Broker Partners